- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SELVITA Aktie jetzt für 0€ handeln | |||||
| Do | Selvita Reports Significant Recovery in H2 2024, Sees Promising Outlook for the Future | 63 | PR Newswire | KRAKÓW, Poland, Nov. 21, 2024 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe, has published... ► Artikel lesen | |
| 24.09. | Selvita S.A.: Selvita reports growing sales in Q2 and Q3, and projects increased profitability in H2 2024 | 349 | PR Newswire | KRAKÓW, Poland, Sept. 24, 2024 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe, has published its financial results for Q2 2024... ► Artikel lesen |
2 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CORE ONE LABS | 0,079 | 0,00 % | New Core One 3D Printer From Prusa May Be the Answer to Its Bambu Problem | ||
| PALATIN TECHNOLOGIES | 0,949 | +2,59 % | Palatin Technologies Inc. Loss At -$7.82 Mln In Q1 | WASHINGTON (dpa-AFX) - Palatin Technologies Inc. (PTN) announced Loss for first quarter of -$7.82 millionThe company's earnings totaled -$7.82 million, or -$0.39 per share. This compares with... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 2,580 | -9,79 % | COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs | Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE... ► Artikel lesen | |
| AMYRIS | - | - | BioMaP-Consortium Contracts Amyris to Support Domestic Medicines Supply | ||
| HALOZYME THERAPEUTICS | 47,100 | +0,11 % | Evotec: Halozyme bietet 11 Euro pro Aktie | Das US-Biotech-Unternehmen Halozyme hat überraschend ein unverbindliches Übernahmeangebot für Evotec in Höhe von 11 Euro pro Aktie vorgelegt, was das Evotec-Management zu einer zurückhaltenden Reaktion... ► Artikel lesen | |
| GLOW LIFETECH | 0,032 | 0,00 % | Glow LifeTech Corp.: Glow Lifetech Announces Non-Brokered Private Placement Offering of Units and Debt Settlement | Toronto, Ontario--(Newsfile Corp. - November 5, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it intends to complete a non-brokered... ► Artikel lesen | |
| ABCELLERA BIOLOGICS | 2,664 | +0,34 % | AbCellera Reports Q2 2024 Business Results | VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release is reported... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 313,30 | -2,00 % | Bio-Rad Reports Third-Quarter 2024 Financial Results | HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results... ► Artikel lesen | |
| AVID BIOSERVICES | 11,700 | -0,85 % | Avid Bioservices, Inc. (CDMO): A Bull Case Theory | ||
| BIOLINERX | 0,270 | +1,50 % | BioLineRx Q3 2024 Earnings Preview | ||
| MINERVA NEUROSCIENCES | 2,100 | -4,55 % | Minerva Neurosciences, Inc: Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates | BURLINGTON, Mass., Nov. 05, 2024(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business... ► Artikel lesen | |
| GEOVAX LABS | 2,685 | 0,00 % | GeoVax meldet Fortschritte bei Studie zu CLL-Impfstoff-Booster | ||
| AADI BIOSCIENCE | 2,200 | -0,90 % | Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update | FYARRO® sales of $7.2 million for Q3 2024, reflecting 21% year over year sales growth
Aadi continues to focus on FYARRO commercial business and comprehensive strategic... ► Artikel lesen | |
| APPLIED THERAPEUTICS | 8,980 | -2,87 % | Pre-market Movers: Portage Biotech, Veea, Intuitive Machines, Applied Therapeutics, Galmed Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Portage Biotech Inc. (PRTG) is up over 179% at... ► Artikel lesen | |
| OVID THERAPEUTICS | 0,975 | -2,50 % | Ovid Therapeutics Inc.: Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth | NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions... ► Artikel lesen |
Das Unternehmen SELVITA SA kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 12,000 Euro und damit +1,69 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SELVITA SA finden Sie auf Wallstreet Online.
